ESG (Environmental, Social, and Governance) may be an increasingly popular acronym in the business world at the moment, however, it’s far from a new concept. With the term first appeared in the UN’s 2004 “Who Cares Wins” report, it has since given responsible business and investment practices a much-needed hook and served as an effective framework that conscientious companies can build on.

Regarding ESG practices, Taiwanese biological research company GBC attaches great importance to this methodology. As a company with a long history of careful management, it has planted an ESG flag and will certainly continue to do.

Enhancing Sustainability & Trust

Since 1984, GBC has been committed to the research and development of breakthrough, low-cost diagnostic technologies. The company focuses on the greater good and aims to improve the quality of life for people around the world.Sustainability is a core part of the company's ethos. What’s the point of improving the health of the world’s people if in the process it destroys the environment on which they depend?

To this end, GBC has been forthright in its efforts to ensure that all aspects of its research and manufacturing systems are environmentally friendly. From reducing the amount of solvent used in its chromatography and reaction processes to replacing single-use items with reusables, GBC is significantly lowering its carbon footprint—and earning investor confidence in the process.

With recent studies showing that 48% of investors are keen on opportunities that are built around sustainability, GBC, like many other forward-thinking companies, is creating strong and trustworthy foundations in the investment community.

Social & Governance

When it comes to human factors, GBC continues to prove that it takes it equally seriously. The company remains transparent and ethically aware in all its dealings with suppliers, partners, customers and employees. Company Chairman Dr. Lin Zongqing once said, “Openness and honesty are at the core of all aspects of GBC’s operations.

A Healthy Diagnosis

For a company that specializes in developing state-of-the-art diagnostic technology, it's gratifying to know that GBC passes the diagnostic test that defines a modern, principled company. There has been no shortage of scandals in the medical and pharmaceutical industries in recent years, and the GBC is a reminder that medical companies are really just trying to help people, not just make a quick buck.

You can learn more about GBC and its ESG practices by browsing our website here.